Literature DB >> 4163960

Antibodies to corticotrophin and their relation to adrenal function in children receiving corticotrophin therapy.

J Landon, M Friedman, F C Greenwood.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 4163960     DOI: 10.1016/s0140-6736(67)92544-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  9 in total

1.  Development of antibodies during long-term therapy with corticotrophin in rheumatoid arthritis. I. Porcine ACTH.

Authors:  D Glass; J R Daly
Journal:  Ann Rheum Dis       Date:  1971-11       Impact factor: 19.103

2.  Corticotrophin therapy in juvenile chronic polyarthritis (Still's disease) and effect on growth.

Authors:  D W Zutshi; M Friedman; B M Ansell
Journal:  Arch Dis Child       Date:  1971-10       Impact factor: 3.791

3.  Development of antibodies during long-term therapy with corticotrophin in rheumatoid arthritis. II. Zinc tetracosactrin (Depot Synacthen).

Authors:  D Glass; G Nuki; J R Daly
Journal:  Ann Rheum Dis       Date:  1971-11       Impact factor: 19.103

4.  Adverse reactions to Zn1-24 ACTH therapy associated with specific cellular immunity.

Authors:  D Glass; L Roffe; R N Maini; D G Wraith; G Nuki
Journal:  Clin Exp Immunol       Date:  1975-04       Impact factor: 4.330

5.  Acquired Resistance to Corticotropin Therapy in Nephrotic Syndrome: Role of De Novo Neutralizing Antibody.

Authors:  Pei Wang; Yan Zhang; Yu Wang; Andrew S Brem; Zhangsuo Liu; Rujun Gong
Journal:  Pediatrics       Date:  2017-07       Impact factor: 7.124

6.  Calcitonin resistance: clinical and immunologic studies in subjects with Paget's disease of bone treated with porcine and salmon calcitonins.

Authors:  J G Haddad; J G Caldwell
Journal:  J Clin Invest       Date:  1972-12       Impact factor: 14.808

7.  Hypothalamic-pituitary-adrenal function in patients treated with long-term depot tetracosactrin.

Authors:  W J Irvine; D R Cullen; S A Khan; J G Ratcliffe
Journal:  Br Med J       Date:  1971-03-20

8.  Relapse of Nephrotic Syndrome after Adrenocorticotropic Hormone-Induced Remission: Implications of Adrenocorticotropic Hormone Antibodies.

Authors:  Snehal Shrivastava; Bohan Chen; Lance D Dworkin; Deepak K Malhotra; Rujun Gong
Journal:  Am J Nephrol       Date:  2020-03-18       Impact factor: 3.754

9.  Effect of prolonged treatment with tetracosactrin on hypothalamo-pituitary-adrenal function in the rat.

Authors:  J R Hodges; S Mitchley
Journal:  Br J Pharmacol       Date:  1971-12       Impact factor: 8.739

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.